Stockreport

Armata Pharmaceuticals: Intriguing Antibiotic Adjunct, But Too Many Potential Red Flags [Seeking Alpha]

Armata Pharmaceuticals, Inc.  (ARMP) 
PDF AP-SA02, combined with standard-of-care antibiotics, showed superior clinical response rates and hospital metrics versus placebo. ARMP faces significant funding chall [Read more]